ARM Sector Snapshot Q2 2025: Key Trends in Cell and Gene Therapy

Published on: Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine’s Q2 2025 Sector Snapshot showcases pivotal progress in cell and gene therapy, from a rapid in-vivo gene editing treatment that saved an infant’s life to regulatory changes that make CAR-T therapies more accessible. Clinical pipelines are expanding for neurological, cancer, cardiovascular, and metabolic diseases, supported by new policy initiatives and strong investment activity. With multiple therapy approvals expected in the U.S. and Europe this year, the field is poised for significant impact on patient care worldwide.

👉 Read the full article: The Sector Snapshot: Q2 2025

Disclaimer:

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link.